Balanced news tone
News Sentiment
5290 sentiment intelligence
Vertex Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
85/100 classification confidence.
directly relevant articles
high-authority source matches
+0.8% over one week, -5.3% over four weeks, trend inactive, and materially above fair value.
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.09% on Jul 8: Key Drivers Unveiled
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.09% on Jul 8: Key Drivers Unveiled
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 18:15
- Source
- TradingKey
This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal -- Barrons.com
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 07 Jul 2026 18:38
- Source
- Moomoo
Enterprise value to revenue forward of Vertex Corp. – TSE:5290
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 18:18
- Source
- TradingView
CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 07 Jul 2026 00:07
- Source
- Stocktwits
Vertex to buy Crinetics for $10 billion in rare-diseases push
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Reuters
Vertex strikes $10B deal for Crinetics and its endocrine drug portfolio
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 07:00
- Source
- Stock Titan
Buy Vertex with Visa: In-Depth Overview Guide
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Jun 2026 17:56
- Source
- Kabul University
Madrigal Pharmaceuticals Could Become The Next Vertex
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Seeking Alpha
Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Barchart.com
Why is Vertex Pharmaceuticals stock rallying today? By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Investing.com Australia
Vertex Pharmaceuticals Stock Analysis: 1991 IPO Growth and 2026 Outlook - News and Statistics
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 07 May 2026 07:00
- Source
- IndexBox
V2X, INC. ANNOUNCES PRICING OF OFFERING OF APPROXIMATELY 2.0 MILLION SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- PR Newswire
Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- IndexBox
Vertex passes key test in quest to treat kidney diseases
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- CNBC
Vertex Pharmaceuticals Stock Pops 5% On Successful Late Stage Kidney Disease Drug Trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- TIKR.com
S&P 500 Futures Steady in Premarket Trading; Vertex Pharmaceuticals, UFP Industries Lead
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- Barron's
TIME100 Most Influential Companies 2024: Vertex Pharmaceuticals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jan 2026 17:42
- Source
- Time Magazine
V2X, INC. ANNOUNCES SALE OF 2,000,000 SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2025 07:00
- Source
- PR Newswire